[Cerebral degenerative change in association with dyskinesia following neuroleptic treatment (author's transl)].
D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D010300:Parkinson Disease / Q000473:pathology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D013378:Substantia Nigra / Q000473:pathology
D006220:Haloperidol
Hirnveränderungen bei Dyskinesie nach Neuroleptica-Medikation.